M
MedCPU
Health Tech & Medtech · New York City, United States · Founded 2009
MedCPU delivers real-time clinical care advice to hospitals in the United States through its advanced Advisor technology MoreLess
MedCPU is a healthcare technology company that provides real-time clinical decision support solutions to hospitals and healthcare providers in the United States. The company's core product is the Advisor technology, a platform that captures and analyzes clinical data from any Electronic Medical Record (EMR) system in real-time, without the need for complex HL7 integrations. This allows the platform to provide clinicians with immediate, evidence-based advice and alerts at the point of care, helping to improve the quality of patient care, ensure compliance with clinical guidelines, and optimize clinical documentation.
The business model is based on providing its software and services to hospitals. The company's revenue is generated through subscriptions to its platform. MedCPU's target clients are hospitals and healthcare systems that are looking to enhance their clinical decision-making processes and improve patient outcomes. The company operates in the digital health and clinical decision support market, a sector that is experiencing significant growth as healthcare organizations increasingly adopt technology to improve efficiency and quality of care.
Keywords: clinical decision support, healthcare technology, real-time data analysis, EMR integration, patient care, clinical documentation, medical compliance, enterprise decision support, Advisor technology, hospital software
Company overview
MedCPU company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- New York City, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 60.3
Valuation & funding
MedCPU funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | May 2016 | $35M | $140M | UPMC Enterprises · Merck Global Health Innovation Fund | — |
| DEBTDebt | Jul 2015 | $35M | — | Silicon Valley Bank | — |
| SERIES BOther financing | Jul 2015 | $5M | $20M | NRV · Merck Global Health Innovation Fund | — |
| SERIES BOther financing | May 2014 | $9.3M | $37M | Merck Global Health Innovation Fund · Easton Capital Investment Group · NRV | — |
| CONVERTIBLEOther financing | Sep 2011 | $1.3M | — | Undisclosed | — |
| EARLY VCOther financing | Nov 2009 | Undisclosed | — |
Growth signals
MedCPU website traffic
Latest recorded traffic for MedCPU is 5.4K monthly website visits, down 70% over the last three months. MedCPU's team grew 0% over the past year.
Comparisons
MedCPU compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
MedCPU's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where MedCPU has talent and traffic
team presence
In the news
Latest news about MedCPU
Recent press, funding announcements, and product moves mentioning MedCPU — open to read from the original sources.
Market sentiment
What the market is saying about MedCPU
An AI-synthesized read of the highest-engagement posts about MedCPU on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedCPU’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.